Peripheral arterial stiffness in primary aldosteronism

Physiological Research

Volumn 61, Issue 5, 2012, Pages 461-468

  Rosa, J ^a,b   Somloova Z ^a   Petrak O ^a   Strauch B ^a   Indra, T ^a   Senitko M ^c   Zelinka, T ^a   Holaj, R ^a   Widimsky Jr J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Peripheral arterial stiffness; Peripheral pulse wave velocity; Primary aldosteronism

Indexed keywords

ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; FEMALE; FEMORAL ARTERY; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

BLOOD PRESSURE; FEMALE; FEMORAL ARTERY; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; VASCULAR STIFFNESS;

EID: 84873867212     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BERNINI G, GALETTA F, FRANZONI F, BARDINI M, TAURINO C, BERNARDINI M, GHIADONI L, BERNINI M, SANTORO G, SALVETTI A. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 26: 2399-2405, 2008.
2. CATENA C, COLUSSI G, NADALINI E, CHIUCH A, BAROSELLI S, LAPENNA R, SECHI LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80-85, 2008.
3. CHOI CU, KIM EJ, KIM SH, SHIN SY, CHOI UJ, KIM JW, LIM HE, RHA SW, PARK CG, SEO HS, OH DJ. Differing effects of aging on central and peripheral blood pressures and pulse wave velocity: a direct intraarterial study. J Hypertens 28: 1252-1260, 2010.
4. FUNDER JW, CAREY RM, FARDELLA C, GOMEZ-SANCHEZ CE, MANTERO F, STOWASSER M, YOUNG WF Jr, MONTORI VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281, 2008.
5. HOLAJ R, ZELINKA T, WICHTERLE D, PETRAK O, STRAUCH B, WIDIMSKY J Jr. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 25: 1451-1457, 2007.
6. JOFFE HV, ADLER GK. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 10: 31-37, 2005.
7. KHANDANPOUR N, ARMON MP, JENNINGS B, CLARK A, MEYER FJ. The association between ankle brachial pressure index and pulse wave velocity: clinical implication of pulse wave velocity. Angiology 60: 732-738, 2009.
8. MAHMUD A, FEELY J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens 18: 50-55, 2005.
9. MANCIA G, DE BACKER G, DOMINICZAK A, CIFKOVA R, FAGARD R, GERMANO G, GRASSI G, HEAGERTY AM, KJELDSEN SE, LAURENT S, NARKIEWICZ K, RUILOPE L, RYNKIEWICZ A, SCHMIEDER RE, BOUDIER HA, ZANCHETTI A, VAHANIAN A, CAMM J, DE CATERINA R, DEAN V, DICKSTEIN K, FILIPPATOS G, FUNCK-BRENTANO C, HELLEMANS I, KRISTENSEN SD, MCGREGOR K, SECHTEM U, SILBER S, TENDERA M, WIDIMSKY P, ZAMORANO JL, ERDINE S, KIOWSKI W, AGABITI-ROSEI E, AMBROSIONI E, LINDHOLM LH, VIIGIMAA M, ADAMOPOULOS S, AGABITI-ROSEI E, AMBROSIONI E, BERTOMEU V, CLEMENT D, ERDINE S, FARSANG C, GAITA D, LIP G, MALLION JM, MANOLIS AJ, NILSSON PM, O'BRIEN E, PONIKOWSKI P, REDON J, RUSCHITZKA F, TAMARGO J, VAN ZWIETEN P, WAEBER B, WILLIAMS B. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187, 2007.
10. MARTIN-FERNANDEZ B, DE LAS HERAS N, MIANA M, BALLESTEROS S, DELGADO C, SONG S, HINTZE T, CACHOFEIRO V, LAHERA V. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression. J Cardiovasc Pharmacol 57: 114-121, 2011.
11. MARTINEZ DV, ROCHA R, MATSUMURA M, OESTREICHER E, OCHOA-MAYA M, ROUBSANTHISUK W, WILLIAMS GH, ADLER GK. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension 39: 614-618, 2002.
12. MITCHELL GF, HWANG SJ, VASAN RS, LARSON MG, PENCINA MJ, HAMBURG NM, VITA JA, LEVY D, BENJAMIN EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 121: 505-511, 2010.
13. MULATERO P, MONTICONE S, VEGLIO F. Diagnosis and treatment of primary aldosteronism. Rev Endocr Metab Disord 12: 3-9, 2011.
14. PARK S, PARK JB, LAKATTA EG. Association of central hemodynamics with estimated 24-h urinary sodium in patients with hypertension. J Hypertens 29: 1502-1507, 2011.
15. RIZZONI D, PAIARDI S, RODELLA L, PORTERI E, DE CIUCEIS C, REZZANI R, BOARI GE, ZANI F, MICLINI M, TIBERIO GA, GIULINI SM, ROSEI CA, BIANCHI R, ROSEI EA. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab 91: 2638-2642, 2006.
16. ROSSI GP. Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep 12: 342-348, 2010.
17. ROSSI GP, SACCHETTO A, VISENTIN P, CANALI C, GRANIERO GR, PALATINI P, PESSINA AC. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27: 1039-1045, 1996.
18. SAFAR ME, BENETOS A. Factors influencing arterial stiffness in systolic hypertension in the elderly: role of sodium and the renin-angiotensin system. Am J Hypertens 16: 249-258, 2003.
19. SCHIFFRIN EL. Effects of aldosterone on the vasculature. Hypertension 47: 312-318, 2006.
20. ŠOMLÓOVÁ Z, WIDIMSKY J Jr, ROSA J, WICHTERLE D, STRAUCH B, PETRAK O, ZELINKA T, VLKOVA J, MASEK M, DVORAKOVA J, HOLAJ R. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J Hum Hypertens 24: 625-630, 2010.
21. ŠTRAUCH B, ZELINKA T, HAMPF M, BERNHARDT R, WIDIMSKY J Jr. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 17: 349-352, 2003.
22. ŠTRAUCH B, PETRAK O, WICHTERLE D, ZELINKA T, HOLAJ R, WIDIMSKY J Jr. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 19: 909-914, 2006.
23. ŠTRAUCH B, PETRAK O, ZELINKA T, WICHTERLE D, HOLAJ R, KASALICKY M, SAFARIK L, ROSA J, WIDIMSKY J Jr. Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 21: 1086-1092, 2008.
24. TAKEDA Y, KARASHIMA S, YONEDA T. Primary aldosteronism, diagnosis and treatment in Japan. Rev Endocr Metab Disord 12: 21-25, 2011.
25. TSUCHIKURA S, SHOJI T, KIMOTO E, SHINOHARA K, HATSUDA S, KOYAMA H, EMOTO M, NISHIZAWA Y. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis 211: 480-485, 2010.
26. VLACHOPOULOS C, AZNAOURIDIS K, STEFANADIS C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55: 1318-1327, 2010.
27. WILLIAMS GH. Cardiovascular benefits of aldosterone receptor antagonists: what about potassium? Hypertension 46: 265-266, 2005.
28. WU VC, YANG SY, LIN JW, CHENG BW, KUO CC, TSAI CT, CHU TS, HUANG KH, WANG SM, LIN YH, CHIANG CK, CHANG HW, LIN CY, LIN LY, CHIU JS, HU FC, CHUEH SC, HO YL, LIU KL, LIN SL, YEN RF, WU KD. Kidney impairment in primary aldosteronism. Clin Chim Acta 412: 1319-1325, 2011.
29. ZELINKA T, STRAUCH B, PECEN L, WIDIMSKY J Jr. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 18: 107-111, 2004.